Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1982-10-22
1985-01-22
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
424365, 514863, A61K 3105
Patent
active
044952031
ABSTRACT:
Anhydrous composition, stable to oxidation, of anthralin or a derivative thereof.
This composition contains anthralin or a derivative thereof in a carrier composed of (i) at least one fatty acid alkyl ester, the fatty acid having 12 to 18 carbon atoms and the alkyl radical having 2 or 3 carbon atoms, and (ii) at least one thickener taken from the group made up of silicas having particle sizes less than 30 m.mu. and polyethylene powders having densities between 0.9 and 0.96 (g/cm.sup.3).
This composition is used in the treatment of skin diseases, particularly psoriasis.
REFERENCES:
patent: 4203969 (1980-05-01), Yarrow et al.
patent: 4287214 (1981-09-01), Van Scott et al.
patent: 4299826 (1981-11-01), Luedders
patent: 4316902 (1982-02-01), Yu et al.
patent: 4367224 (1983-01-01), Van Scott et al.
Remington's Pharmaceutical Sciences, 16th Ed., 1980, p. 356.
Chemical Abstracts 76:144782y (1972).
Cosmetics, Science & Technology (Balsam et al.), 2nd Ed., vol. 1, pp. 194-195, (1972).
Allec Josiane
Grollier Jean-Francois
Rosenbaum Georges
Shroot Braham
Schenkman Leonard
Societe Anonyme dite: "L'Oreal"
LandOfFree
Anhydrous composition, stable to oxidation, based on anthralin o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydrous composition, stable to oxidation, based on anthralin o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydrous composition, stable to oxidation, based on anthralin o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-566710